Cellular responses to excess fatty acids: Focus on ubiquitin regulatory X domain-containing protein 8

Current Opinion in Lipidology

Volumn 25, Issue 2, 2014, Pages 118-124

  Kim, Hyeonwoo ^a   Ye, Jin ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Fatty acids; LXR; PPARs; SREBP 1; UBXD8

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ACYL COENZYME A DESATURASE 1; FATTY ACID; LIVER X RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; POLYUNSATURATED FATTY ACID; RETINOID X RECEPTOR; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; UBIQUITIN; UBIQUITIN REGULATORY X DOMAIN-CONTAINING PROTEIN 8; UNCLASSIFIED DRUG; UNSATURATED FATTY ACID;

ADIPOGENESIS; CELL DIFFERENTIATION; CELL SURVIVAL; ENZYME INHIBITION; FATTY ACID OXIDATION; FATTY ACID SYNTHESIS; GENE ACTIVATION; GENETIC TRANSCRIPTION; HOMEOSTASIS; HUMAN; LIGAND BINDING; LIPID STORAGE; LIPOTOXICITY; METABOLIC SYNDROME X; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

ADIPOGENESIS; ANIMALS; BLOOD PROTEINS; FATTY ACIDS; HUMANS; MEMBRANE PROTEINS; ORPHAN NUCLEAR RECEPTORS; OXIDATION-REDUCTION; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS;

EID: 84897025999     PISSN: 09579672     EISSN: 14736535     Source Type: Journal    
DOI: 10.1097/MOL.0000000000000048     Document Type: Review

References (57)

1. Smathers RL, Petersen DR. The human fatty acid-binding protein family: Evolutionary divergences and functions. Hum Genomics 2011; 5:170-191.
2. Robinson E, Grieve DJ. Significance of peroxisome proliferator-Activated receptors in the cardiovascular system in health and disease. Pharmacol Ther 2009; 122:246-263.
3. Monsalve FA, Pyarasani RD, Delgado-Lopez F, Moore-Carrasco R. Peroxisome proliferator-Activated receptor targets for the treatment of metabolic diseases. Mediators Inflamm 2013; 549627.
4. Kliewer SA, Forman BM, Blumberg B, et al. Differential expression and activation of a family of murine peroxisome proliferator-Activated receptors. Proc Natl Acad Sci USA 1994; 91:7355-7359.
5. Braissant O, Foufelle F, Scotto C, et al. Differential expression of peroxisome proliferator-Activated receptors (PPARs): Tissue distribution of PPAR-A,-b, and-g in the adult rat. Endocrinology 1996; 137:354-366.
6. Tugwood JD, Issemann I, Anderson RG, et al. The mouse peroxisome proliferator activated receptor recognizes a response element in the 50 flanking sequence of the rat acyl CoA oxidase gene. EMBO J 1992; 11:433-439.
7. Marcus SL, Miyata KS, Zhang B, et al. Diverse peroxisome proliferator-Activated receptors bind to the peroxisome proliferator-responsive elements of the rat hydratase/dehydrogenase and fatty acyl-CoA oxidase genes but differentially induce expression. Proc Natl Acad Sci USA 1993; 90:5723-5727.
8. Zhang B, Marcus SL, Sajjadi FG, et al. Identification of a peroxisome proliferator-responsive element upstream of the gene encoding rat peroxisomal enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase. Proc Natl Acad Sci USA 1992; 89:7541-7545.
9. Mascaro C, Acosta E, Ortiz JA, et al. Control of human muscle-Type carnitine palmitoyltransferase I gene transcription by peroxisome proliferator-Activated receptor. J Biol Chem 1998; 273:8560-8563.
10. Cheng L, Ding G, Qin Q, et al. Cardiomyocyte-restricted peroxisome proliferator-Activated receptor-d deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy. Nat Med 2004; 10:1245-1250.
11. Tanaka T, Yamamoto J, Iwasaki S, et al. Activation of peroxisome proliferatoractivated receptor d induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome. Proc Natl Acad Sci USA 2003; 100:15924-15929.
12. Tontonoz P, Hu E, Graves RA, et al. mPPAR g2: Tissue-specific regulator of an adipocyte enhancer. Genes Dev 1994; 8:1224-1234.
13. Tontonoz P, Hu E, Devine J, et al. PPAR gamma 2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene. Mol Cell Biol 1995; 15:351-357.
14. Xu HE, Lambert MH, Montana VG, et al. Molecular recognition of fatty acids by peroxisome proliferator-Activated receptors. Mol Cell 1999; 3:397-403.
15. Itoh T, Fairall L, Amin K, et al. Structural basis for the activation of PPARg by oxidized fatty acids. Nat Struct Mol Biol 2008; 15:924-931.
16. Gampe RT Jr, Montana VG, Lambert MH, et al. Asymmetry in the PPARg/ RXRa crystal structure reveals the molecular basis of heterodimerization among nuclear receptors. Mol Cell 2000; 5:545-555.
17. Forman BM, Chen J, Evans RM. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-Activated receptors a and d. Proc Natl Acad Sci USA 1997; 94:4312-4317.
18. Krey G, Keller H, Mahfoudi A, et al. Xenopus peroxisome proliferator activated receptors: Genomic organization, response element recognition, heterodimer formation with retinoid X receptor and activation by fatty acids. J Steroid Biochem Mol Biol 1993; 47:65-73.
19. Kliewer SA, Sundseth SS, Jones SA, et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-Activated receptors a and g. Proc Natl Acad Sci USA 1997; 94:4318-4323.
20. Leone TC, Weinheimer CJ, Kelly DP. A critical role for the peroxisome proliferator-Activated receptor a (PPARa) in the cellular fasting response: The PPARa-null mouse as a model of fatty acid oxidation disorders. Proc Natl Acad Sci USA 1999; 96:7473-7478.
21. Patsouris D, Reddy JK, Muller M, Kersten S. Peroxisome proliferator-Activated receptor a mediates the effects of high-fat diet on hepatic gene expression. Endocrinology 2006; 147:1508-1516.
22. He W, Barak Y, Hevener A, et al. Adipose-specific peroxisome proliferatoractivated receptor g knockout causes insulin resistance in fat and liver but not in muscle. Proc Natl Acad Sci USA 2003; 100:15712-15717.
23. Jones JR, Barrick C, Kim KA, et al. Deletion of PPARg in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance. Proc Natl Acad Sci USA 2005; 102:6207-6212.
24. Ducheix S, Montagner A, Theodorou V, et al. The liver X receptor: A master regulator of the gut-liver axis and a target for non alcoholic fatty liver disease. Biochem Pharmacol 2013; 86:96-105.
25. Edwards PA, Kennedy MA, Mak PA. LXRs; oxysterol-Activated nuclear receptors that regulate genes controlling lipid homeostasis. Vascul Pharmacol 2002; 38:249-256.
26. Repa JJ, Mangelsdorf DJ. The role of orphan nuclear receptors in the regulation of cholesterol homeostasis. Annu Rev Cell Dev Biol 2000; 16:459-481.
27. Joseph SB, Laffitte BA, Patel PH, et al. Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors. J Biol Chem 2002; 277:11019-11025.
28. Chu K, Miyazaki M, Man WC, Ntambi JM. Stearoyl-coenzyme A desaturase 1 deficiency protects against hypertriglyceridemia and increases plasma highdensity lipoprotein cholesterol induced by liver X receptor activation. Mol Cell Biol 2006; 26:6786-6798.
29. Talukdar S, Hillgartner FB. The mechanism mediating the activation of acetylcoenzyme A carboxylase-A gene transcription by the liver X receptor agonist T0-901317. J Lipid Res 2006; 47:2451-2461.
30. Repa JJ, Liang G, Ou J, et al. Regulation of mouse sterol regulatory elementbinding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRa and LXRb. Genes Dev 2000; 14:2819-2830.
31. Ye J, DeBose-Boyd RA. Regulation of cholesterol and fatty acid synthesis. Cold Spring Harb Perspect Biol 2011; 3:a004754.
32. Glass CK, Rose DW, Rosenfeld MG. Nuclear receptor coactivators. Curr Opin Cell Biol 1997; 9:222-232.
33. Sampath H, Ntambi JM. Polyunsaturated fatty acid regulation of genes of lipid metabolism. Annu Rev Nutr 2005; 25:317-340.
34. Ou J, Tu H, Shan B, et al. Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c (SREBP-1c) gene by antagonizing ligand-dependent activation of the LXR. Proc Natl Acad Sci USA 2001; 98:6027-6032.
35. Hannah VC, Ou J, Luong A, et al. Unsaturated fatty acids down-regulate srebp isoforms 1a and 1c by two mechanisms in HEK-293 cells. J Biol Chem 2001; 276:4365-4372.
36. Jung UJ, Millman PN, Tall AR, Deckelbaum RJ. n-3 fatty acids ameliorate hepatic steatosis and dysfunction after LXR agonist ingestion in mice. Biochim Biophys Acta 2011; 9:491-497.
37. Lee JN, Kim H, Yao H, et al. Identification of UBXD8 protein as a sensor for unsaturated fatty acids and regulator of triglyceride synthesis. Proc Natl Acad Sci USA 2010; 107:21424-21429.
38. Zehmer JK, Bartz R, Bisel B, et al. Targeting sequences of UBXD8 and AAM-B reveal that the ER has a direct role in the emergence and regression of lipid droplets. J Cell Sci 2009; 122:3694-3702.
39. Olzmann JA, Richter CM, Kopito RR. Spatial regulation of UBXD8 and p97/ VCP controls ATGL-mediated lipid droplet turnover. Proc Natl Acad Sci USA 2013; 110:1345-1350.
40. Buchberger A. From UBA to UBX: New words in the ubiquitin vocabulary. Trends Cell Biol 2002; 12:216-221.
41. Halawani D, Latterich M. p97: The cell's molecular purgatory? Mol Cell 2006; 22:713-717.
42. Kim H, Zhang H, Meng D, et al. UAS domain of UBXD8 and FAF1 polymerizes upon interaction with long-chain unsaturated fatty acids. J Lipid Res 2013; 54:2144-2152.
43. Lee JN, Zhang X, Feramisco JD, et al. Unsaturated fatty acids inhibit proteasomal degradation of INSIG-1 at a postubiquitination step. J Biol Chem 2008; 283:33772-33783.
44. Brown MS, Goldstein JL. The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 1997; 89:331-340.
45. Sakai J, Nohturfft A, Cheng D, et al. Identification of complexes between the COOH-Terminal domains of sterol regulatory element-binding proteins (SREBPs) and SREBP cleavage-Activating protein. J Biol Chem 1997; 272:20213-20221.
46. Yang T, Espenshade PJ, Wright ME, et al. Crucial step in cholesterol homeostasis: Sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER. Cell 2002; 110:489-500.
47. Sun LP, Li L, Goldstein JL, Brown MS. Insig required for sterol-mediated inhibition of SCAP/SREBP binding to COPII proteins in vitro. J Biol Chem 2005; 280:26483-26490.
48. DeBose-Boyd RA, Brown MS, Li WP, et al. Transport-dependent proteolysis of SREBP: Relocation of site-1 protease from Golgi to ER obviates the need for SREBP transport to Golgi. Cell 1999; 99:703-712.
49. Nohturfft A, Yabe D, Goldstein JL, et al. Regulated step in cholesterol feedback localized to budding of SCAP from ER membranes. Cell 2000; 102:315-323.
50. Sakai J, Rawson RB, Espenshade PJ, et al. Molecular identification of the sterol-regulated luminal protease that cleaves SREBPs and controls lipid composition of animal cells. Mol Cell 1998; 2:505-514.
51. Rawson RB, Zelenski NG, Nijhawan D, et al. Complementation cloning of S2P, a gene encoding a putative metalloprotease required for intramembrane cleavage of SREBPs. Mol Cell 1997; 1:47-57.
52. Horton JD, Shah NA, Warrington JA, et al. Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. Proc Natl Acad Sci USA 2003; 100:12027-12032.
53. Yen CL, Stone SJ, Koliwad S, et al. Thematic review series: Glycerolipids. DGAT enzymes and triacylglycerol biosynthesis. J Lipid Res 2008; 49:2283-2301.
54. Coll T, Eyre E, Rodriguez-Calvo R, et al. Oleate reverses palmitate-induced insulin resistance and inflammation in skeletal muscle cells. J Biol Chem 2008; 283:11107-11116.
55. Zhao TJ, Liang G, Li RL, et al. Ghrelin O-Acyltransferase (GOAT) is essential for growth hormone-mediated survival of calorie-restricted mice. Proc Natl Acad Sci USA 2010; 107:7467-7472.
56. Dobrzyn A, Ntambi JM. The role of stearoyl-CoA desaturase in the control of metabolism. Prostaglandins Leukot Essent Fatty Acids 2005; 73:35-41.
57. Erion DM, Shulman GI. Diacylglycerol-mediated insulin resistance. Nat Med 2010; 16:400-402.